Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
55,439,550
-
Share change
-
+1,166,909
-
Total reported value
-
$1,628,256,106
-
Put/Call ratio
-
32%
-
Price per share
-
$29.37
-
Number of holders
-
188
-
Value change
-
+$3,161,123
-
Number of buys
-
90
-
Number of sells
-
101
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q3 2018
As of 30 Sep 2018,
CLOVIS ONCOLOGY INC - COM (CLVSQ) was held by
188 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,439,550 shares.
The largest 10 holders included
Palo Alto Investors LP, Vanguard Group Inc, BlackRock Inc., STATE STREET CORP, PointState Capital LP, ORBIMED ADVISORS LLC, Partner Fund Management, L.P., Redmile Group, LLC, FRANKLIN RESOURCES INC, and Camber Capital Management LP.
This page lists
188
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.